IN2014DN09779A - - Google Patents

Info

Publication number
IN2014DN09779A
IN2014DN09779A IN9779DEN2014A IN2014DN09779A IN 2014DN09779 A IN2014DN09779 A IN 2014DN09779A IN 9779DEN2014 A IN9779DEN2014 A IN 9779DEN2014A IN 2014DN09779 A IN2014DN09779 A IN 2014DN09779A
Authority
IN
India
Prior art keywords
osteoporosis
vitamin
per day
bone tissue
drone brood
Prior art date
Application number
Other languages
English (en)
Inventor
Villorij Ivanovich Strukov
Olga Jhones
Evgenij Nikolaevich Krutiakov
Konstantin Gennad Evich Elistratov
Original Assignee
Obschestvo S Ogranichennoj Otvetstvennostju Parafarm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Ogranichennoj Otvetstvennostju Parafarm filed Critical Obschestvo S Ogranichennoj Otvetstvennostju Parafarm
Publication of IN2014DN09779A publication Critical patent/IN2014DN09779A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Insects & Arthropods (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IN9779DEN2014 2012-04-19 2014-11-19 IN2014DN09779A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012115653/15A RU2498811C1 (ru) 2012-04-19 2012-04-19 Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
PCT/RU2012/000689 WO2013157984A1 (ru) 2012-04-19 2012-08-21 Препарат и способ профилактики и лечения остеопороза и переломов костей

Publications (1)

Publication Number Publication Date
IN2014DN09779A true IN2014DN09779A (ru) 2015-07-31

Family

ID=49383802

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9779DEN2014 IN2014DN09779A (ru) 2012-04-19 2014-11-19

Country Status (13)

Country Link
US (1) US20150174176A1 (ru)
EP (1) EP2875820A4 (ru)
JP (1) JP6286418B2 (ru)
CN (1) CN104379154A (ru)
AU (1) AU2012377478B2 (ru)
BR (1) BR112014025973B1 (ru)
CA (1) CA2870828C (ru)
EA (1) EA026534B1 (ru)
IL (1) IL235171B (ru)
IN (1) IN2014DN09779A (ru)
RU (1) RU2498811C1 (ru)
UA (1) UA111280C2 (ru)
WO (1) WO2013157984A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2548776C2 (ru) * 2013-01-11 2015-04-20 Общество С Ограниченной Ответственностью "Парафарм" Способ и препарат для ускорения консолидации переломов костей
RU2549461C2 (ru) * 2013-01-11 2015-04-27 Общество С Ограниченной Ответственностью "Парафарм" Способ и препарат для лечения артритов и артрозов
RU2564111C9 (ru) * 2013-07-03 2016-03-20 Общество С Ограниченной Ответственностью "Парафарм" Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа
RU2593018C1 (ru) * 2015-10-28 2016-07-27 Общество С Ограниченной Ответственностью "Парафарм" Способ лечения остеоартроза

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743596A (en) * 1987-06-16 1988-05-10 Lapin Alfred R Anti-arthritic preparation
CN1101684C (zh) * 1997-07-24 2003-02-19 薛大权 蜂蛹钙制剂
WO2002013832A1 (fr) * 2000-08-17 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Agent therapeutique destine au traitement de l'osteoporose
JP2007525953A (ja) * 2003-06-06 2007-09-13 ワイス 骨リモデリングを調節する物質を同定するための方法および材料、ならびにそれによって同定された物質
CN104758301A (zh) * 2008-02-13 2015-07-08 帝斯曼知识产权资产管理有限公司 维生素d3和25-羟基-维生素d3的组合用途
FR2945748A1 (fr) * 2009-05-20 2010-11-26 Debregeas Et Associes Pharma Medicament a base de calcium et de vitamine d.
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом
RU2497533C1 (ru) * 2012-04-19 2013-11-10 Общество С Ограниченной Ответственностью "Парафарм" Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)

Also Published As

Publication number Publication date
IL235171B (en) 2019-09-26
RU2498811C1 (ru) 2013-11-20
IL235171A0 (en) 2014-12-31
US20150174176A1 (en) 2015-06-25
CN104379154A (zh) 2015-02-25
AU2012377478A8 (en) 2014-12-18
JP6286418B2 (ja) 2018-02-28
JP2015514755A (ja) 2015-05-21
WO2013157984A1 (ru) 2013-10-24
CA2870828C (en) 2019-01-15
CA2870828A1 (en) 2013-10-24
UA111280C2 (uk) 2016-04-11
AU2012377478B2 (en) 2017-07-06
AU2012377478A1 (en) 2014-12-11
BR112014025973B1 (pt) 2021-09-28
EP2875820A1 (en) 2015-05-27
EA201401157A1 (ru) 2015-05-29
EA026534B1 (ru) 2017-04-28
BR112014025973A2 (pt) 2017-06-27
EP2875820A4 (en) 2016-01-27

Similar Documents

Publication Publication Date Title
MX2022003072A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
GB201100043D0 (en) Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
IN2014DN09779A (ru)
EA201001286A1 (ru) Комбинированное применение 25-гидроксивитамина d3 и витамина d3 для повышения плотности минерального вещества костей и для лечения остеопороза
MX335951B (es) Agente terapeutico/profilactico que contiene pth para la osteoporosis, caracterizado porque la pth se administra una vez a la semana en una dosis unitaria de 100 a 200 unidades.
MX2016009231A (es) Administracion de tasimelteon en condiciones de ayuno.
IN2014DN09780A (ru)
WO2010008976A3 (en) Combined calcium, magnesium and vitamin d supplements
RU2017120184A (ru) Лекарства для замедления течения болезни паркинсона
MX2017000886A (es) Tratamiento con cis-clomifeno de sofocos y perdida osea inducidos por privacion de androgeno terapeutica.
MX2022013681A (es) Metodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis.
WO2012166003A1 (ru) Способ заполнения кальцием полостных образований костей
MX2018005876A (es) Regimen de dosificacion de plasminogeno para la cicatrizacion de heridas.
JOP20170044B1 (ar) تركيبة صيدلانية تشتمل على hgh ناتج عن عودة الارتباط الجيني لعلاج نقص هرمون النمو
MX2012003892A (es) Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante.
MX2020001217A (es) Metodos de tratamiento de sintomas de gastroparesia usando velusetrag.
EA201990553A1 (ru) Применение придопидина для лечения ухудшения функциональной способности
BR112022003567A2 (pt) Forma de dosagem oral sólida compreendendo naproxeno e vitamina b1
PL3246032T3 (pl) Kompozycje farmaceutyczne z kwasem zoledronowym, wapniem i witaminą d, odpowiednie do leczenia i/lub profilaktyki chorób metabolicznych kości oraz działań ubocznych spowodowanych terapią, takich jak hipokalcemia
Perez Alendronic acid
UA97257U (ru) Способ профилактики и лечения сердечно-сосудистых заболеваний
UA53407U (ru) Способ профилактики и лечения перенашевания беременности
UA33494U (ru) Фармацевтическая композиция для лечения заболеваний костной ткани
RU2013147359A (ru) Способ коррекции состояния костной ткани и профилактики возникновения переломов у больных с сердечно-сосудистыми заболеваниями